Gene · 1241
Papers1,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Pharmacological Review of Calcitonin Gene-Related Peptide Biologics and Future Use for Chronic Pain. | Cureus | 2023 | 36945265 | PubTator, text mining | PubMed |
| Regularized survival learning and cross-database analysis enabled identification of colorectal cancer prognosis-related immune genes. | Front Genet | 2023 | 36911403 | PubTator, text mining | PubMed |
| The Pleiotropic Role of Extracellular ATP in Myocardial Remodelling. | Molecules | 2023 | 36903347 | PubTator, text mining | PubMed |
| Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling. | Diagnostics (Basel) | 2023 | 36900088 | PubTator, text mining | PubMed |
| The role of G protein-coupled receptor in neutrophil dysfunction during sepsis-induced acute respiratory distress syndrome. | Front Immunol | 2023 | 36891309 | PubTator, text mining | PubMed |
| Biasing AlphaFold2 to predict GPCRs and kinases with user-defined functional or structural properties. | Front Mol Biosci | 2023 | 36876042 | PubTator, text mining | PubMed |
| Contributions of the receptor for advanced glycation end products axis activation in gastric cancer. | World J Gastroenterol | 2023 | 36844144 | PubTator, text mining | PubMed |
| Lipids as Targets for Renal Cell Carcinoma Therapy. | Int J Mol Sci | 2023 | 36834678 | PubTator, text mining | PubMed |
| Mechanisms of Transmission and Processing of Pain: A Narrative Review. | Int J Environ Res Public Health | 2023 | 36833753 | PubTator, text mining | PubMed |
| Structural basis of lysophosphatidylserine receptor GPR174 ligand recognition and activation. | Nat Commun | 2023 | 36823105 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa Acquisita-Current and Emerging Treatments. | J Clin Med | 2023 | 36769788 | PubTator, text mining | PubMed |
| Huangshui Polysaccharide Exerts Intestinal Barrier Protective Effects through the TLR4/MyD88/NF-κB and MAPK Signaling Pathways in Caco-2 Cells. | Foods | 2023 | 36765977 | PubTator, text mining | PubMed |
Synthesis and Significance of Arachidonic Acid, a Substrate for Cyclooxygenases, Lipoxygenases, and Cytochrome P450 Pathways in the Tumorigenesis of Glioblastoma Multiforme, Including a Pan-Cancer Comparative Analysis. | Cancers (Basel) | 2023 | 36765904 | PubTator, text mining | PubMed |
| An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis. | Cancers (Basel) | 2023 | 36765694 | PubTator, text mining | PubMed |
| Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. | Biochem Pharmacol | 2023 | 36731803 | PubTator, text mining | PubMed |
| Neutrophil heterogeneity and emergence of a distinct population of CD11b/CD18-activated low-density neutrophils after trauma. | J Trauma Acute Care Surg | 2023 | 36694330 | PubTator, text mining | PubMed |
| The leukotriene B4 /BLT1-dependent neutrophil accumulation exacerbates immune complex-mediated glomerulonephritis. | FASEB J | 2023 | 36692419 | PubTator, text mining | PubMed |
| Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma. | BMC Gastroenterol | 2023 | 36681801 | PubTator, text mining | PubMed |
| Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis. | Int J Mol Sci | 2023 | 36675152 | PubTator, text mining | PubMed |
| Identification of immune associated potential molecular targets in proliferative diabetic retinopathy. | BMC Ophthalmol | 2023 | 36658547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1241/papers?page=8